Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy.
Dyskinetic cerebral palsy (CP) is a movement disorder that is difficult to treat and which causes major disability. We report on two female patients (aged 5y and 8y) who experienced severe perinatal asphyxia and developed dyskinetic CP, clinically characterized by choreoathetosis. Neuropsychological testing of these children showed a low average developmental quotient and no attentional deficit. Monotherapy with levetiracetam was initiated to improve balance control and fine motor skills. Treatment was evaluated by use of video and the Visual Analog Scale. In both children an impressive improvement of balance control and fine motor skills was observed. No side effect occurred. Furthermore, both patients showed more interest and pleasure during activities according to their parents. In a recent multidisciplinary evaluation of the initiated therapy, the parents, the therapist, and the rehabilitation doctor all confirmed that the effect initially observed was still present at 14 and 26 months later. To our knowledge, this report on two patients with dyskinetic CP is the first suggesting that levetiracetam may offer an alternative to the standard therapy of involuntary, uncontrolled movements in this group of patients.
Vles
G F
GF
Department of Child Neurology, University Hospital Maastricht, Maastricht, The Netherlands. g.vles@student.unimaas.nl
Hendriksen
J G
JG
Visschers
A
A
Speth
L
L
Nicolai
J
J
Vles
J S H
JS
D000927:Anticonvulsants / Q000627:therapeutic use*; D001264:Athetosis / Q000188:drug therapy*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002819:Chorea / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D009048:Motor Skills / Q000187:drug effects; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000927:Anticonvulsants; D000077287:Levetiracetam; D010889:Piracetam